These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 15149841)

  • 1. Wnt and beta-catenin signaling target the expression of ecto-5'-nucleotidase and increase extracellular adenosine generation.
    Spychala J; Kitajewski J
    Exp Cell Res; 2004 Jun; 296(2):99-108. PubMed ID: 15149841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-talk between Rac1 GTPase and dysregulated Wnt signaling pathway leads to cellular redistribution of beta-catenin and TCF/LEF-mediated transcriptional activation.
    Esufali S; Bapat B
    Oncogene; 2004 Oct; 23(50):8260-71. PubMed ID: 15377999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WNT-1 and HGF regulate GSK3 beta activity and beta-catenin signaling in mammary epithelial cells.
    Papkoff J; Aikawa M
    Biochem Biophys Res Commun; 1998 Jun; 247(3):851-8. PubMed ID: 9647782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-catenin/Tcf activation partially mimics the transforming activity of Wnt-1 in Rat-1 fibroblasts.
    Young CS; Masckauchan TN; Kitajewski J
    Differentiation; 2003 Oct; 71(8):477-85. PubMed ID: 14641328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of cyclooxygenase-2 expression by the Wnt and ras pathways.
    Araki Y; Okamura S; Hussain SP; Nagashima M; He P; Shiseki M; Miura K; Harris CC
    Cancer Res; 2003 Feb; 63(3):728-34. PubMed ID: 12566320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel candidate targets of beta-catenin/T-cell factor signaling identified by gene expression profiling of ovarian endometrioid adenocarcinomas.
    Schwartz DR; Wu R; Kardia SL; Levin AM; Huang CC; Shedden KA; Kuick R; Misek DE; Hanash SM; Taylor JM; Reed H; Hendrix N; Zhai Y; Fearon ER; Cho KR
    Cancer Res; 2003 Jun; 63(11):2913-22. PubMed ID: 12782598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A GSK3beta phosphorylation site in axin modulates interaction with beta-catenin and Tcf-mediated gene expression.
    Jho Eh; Lomvardas S; Costantini F
    Biochem Biophys Res Commun; 1999 Dec; 266(1):28-35. PubMed ID: 10581160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of a beta-catenin-LEF-1 complex by wnt-1 and transforming mutants of beta-catenin.
    Porfiri E; Rubinfeld B; Albert I; Hovanes K; Waterman M; Polakis P
    Oncogene; 1997 Dec; 15(23):2833-9. PubMed ID: 9419974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wnt-1 and int-2 mammary oncogene effects on the beta-catenin pathway in immortalized mouse mammary epithelial cells are not sufficient for tumorigenesis.
    Hollmann CA; Kittrell FS; Medina D; Butel JS
    Oncogene; 2001 Nov; 20(52):7645-57. PubMed ID: 11753642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tcf binding sequence and position determines beta-catenin and Lef-1 responsiveness of MMP-7 promoters.
    Gustavson MD; Crawford HC; Fingleton B; Matrisian LM
    Mol Carcinog; 2004 Nov; 41(3):125-39. PubMed ID: 15457508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of Wnt-1 in thyrocytes enhances cellular growth but suppresses transcription of the thyroperoxidase gene via different signaling mechanisms.
    Kim WB; Lewis CJ; McCall KD; Malgor R; Kohn AD; Moon RT; Kohn LD
    J Endocrinol; 2007 Apr; 193(1):93-106. PubMed ID: 17400807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Constitutive activation of Wnt/beta-catenin signaling pathway in migration-active melanoma cells: role of LEF-1 in melanoma with increased metastatic potential.
    Murakami T; Toda S; Fujimoto M; Ohtsuki M; Byers HR; Etoh T; Nakagawa H
    Biochem Biophys Res Commun; 2001 Oct; 288(1):8-15. PubMed ID: 11594745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wnt signaling is required for thymocyte development and activates Tcf-1 mediated transcription.
    Staal FJ; Meeldijk J; Moerer P; Jay P; van de Weerdt BC; Vainio S; Nolan GP; Clevers H
    Eur J Immunol; 2001 Jan; 31(1):285-93. PubMed ID: 11265645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SKI activates Wnt/beta-catenin signaling in human melanoma.
    Chen D; Xu W; Bales E; Colmenares C; Conacci-Sorrell M; Ishii S; Stavnezer E; Campisi J; Fisher DE; Ben-Ze'ev A; Medrano EE
    Cancer Res; 2003 Oct; 63(20):6626-34. PubMed ID: 14583455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative evaluation of beta-catenin and plakoglobin signaling activity.
    Williams BO; Barish GD; Klymkowsky MW; Varmus HE
    Oncogene; 2000 Nov; 19(50):5720-8. PubMed ID: 11126358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Wnt antagonist DICKKOPF-1 gene is a downstream target of beta-catenin/TCF and is downregulated in human colon cancer.
    González-Sancho JM; Aguilera O; García JM; Pendás-Franco N; Peña C; Cal S; García de Herreros A; Bonilla F; Muñoz A
    Oncogene; 2005 Feb; 24(6):1098-103. PubMed ID: 15592505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant expression and function of TCF4 in the proliferation of hepatocellular carcinoma cell line BEL-7402.
    Zhao DH; Hong JJ; Guo SY; Yang RL; Yuan J; Wen CY; Zhou KY; Li CJ
    Cell Res; 2004 Feb; 14(1):74-80. PubMed ID: 15040893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphoid enhancer factor 1 makes cells resistant to transforming growth factor beta-induced repression of c-myc.
    Sasaki T; Suzuki H; Yagi K; Furuhashi M; Yao R; Susa S; Noda T; Arai Y; Miyazono K; Kato M
    Cancer Res; 2003 Feb; 63(4):801-6. PubMed ID: 12591729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wnt induction of chondrocyte hypertrophy through the Runx2 transcription factor.
    Dong YF; Soung do Y; Schwarz EM; O'Keefe RJ; Drissi H
    J Cell Physiol; 2006 Jul; 208(1):77-86. PubMed ID: 16575901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The human T-cell factor-4 gene splicing isoforms, Wnt signal pathway, and apoptosis in renal cell carcinoma.
    Shiina H; Igawa M; Breault J; Ribeiro-Filho L; Pookot D; Urakami S; Terashima M; Deguchi M; Yamanaka M; Shirai M; Kaneuchi M; Kane CJ; Dahiya R
    Clin Cancer Res; 2003 Jun; 9(6):2121-32. PubMed ID: 12796377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.